weight loss difference between semaglutide and tirzepatide vs. Semaglutide: What's the Difference? Semaglutide vs Tirzepatide: Weight Loss,

Understanding those tradeoffs requires knowing why compounded versions exist and why that origin story matters more than most people realize

Even large trials/registries may lack power for small absolute risk increases Follow-up duration: Most studies provide 2-5 years observationsufficient for short-term safety, potentially insufficient for very long latency Histologic subtype adjudication often incomplete

They may vary in potency and quality compared to brand-name products

Fortunately, GLP1 medications are now FDA-indicated for multiple indications beyond weight management and diabetes, including: Major cardiovascular event (heart attack and/or stroke) risk reduction in adults with cardiovascular disease and overweight or obesity Metabolic dysfunctionassociated steatohepatitis (MASH) Moderate to severe obstructive sleep apnea (OSA) in adults with obesity When one medication can address multiple conditions, it simplifies care and reduces polypharmacy